Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Neurology

Journal Scan / Research · October 25, 2022

Astrocyte Biomarker Signatures of Amyloid-β and Tau Pathologies in Alzheimer's Disease

Molecular Psychiatry


Additional Info

Molecular Psychiatry
Astrocyte biomarker signatures of amyloid-β and tau pathologies in Alzheimer's disease
Mol. Psychiatry 2022 Aug 10;[EPub Ahead of Print], JP Ferrari-Souza, PCL Ferreira, B Bellaver, C Tissot, YT Wang, DT Leffa, WS Brum, AL Benedet, NJ Ashton, MA De Bastiani, A Rocha, J Therriault, FZ Lussier, M Chamoun, S Servaes, G Bezgin, MS Kang, J Stevenson, N Rahmouni, V Pallen, NM Poltronetti, WE Klunk, DL Tudorascu, AD Cohen, VL Villemagne, S Gauthier, K Blennow, H Zetterberg, DO Souza, TK Karikari, ER Zimmer, P Rosa-Neto, TA Pascoal

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading